ArticlePulmonary circulation2024

Safety, tolerability, and efficacy of an in-class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension.

Cara Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.